Cipla shares jump 5% after promoter family sells 2.5% stake
The promoter group sold 2.53% stake in Cipla, worth around ₹2,637 crore, via block deal today.
The promoter group sold 2.53% stake in Cipla, worth around ₹2,637 crore, via block deal today.
The share price of Cipla touched a new record high of ₹1,408.55, while market capitalisation climbed to ₹1.12 lakh crore.
Warning letter stresses data integrity issues at company embedded with product complaints and microbial contamination
The Indian production facility of Mondelez, Dr. Reddy’s, and Cipla have joined WEF's Global Lighthouse Network
The Sensex and Nifty are poised to open higher on Tuesday, following firm cues from Asian markets and positive trends on SGX Nifty.
The Sensex and Nifty are poised to open on a soft note on Wednesday, tracking mixed cues from global peers as looming fear about aggressive rate hikes weighed on investors’ sentiments.
The pharma stock has generated a 10% return in the past year but has remained flat since the beginning of the calendar year 2022.
The BSE Sensex and the NSE Nifty are expected to open lower on Thursday as stocks tumbled on Wall Street and in Asia, while trends on SGX Nifty also indicated a gap-down opening for domestic bourses.
All the sectoral indices ended in the green, while capital goods, auto IT, and PSU bank gained the most, led by Asian Paints, Sun Pharma, and M&M.
Almost every major Indian pharmaceutical company, including Cipla, Dr Reddy’s, Sun Pharma and Biocon, are on the list of companies which can produce mRNA Covid-19 vaccines